Signaling pathways
-
BA2703 DL-01Summary: DL-01 is an ADC active molecule-linker coupling. -
BA2704 SC-VC-PAB-DM1Summary: SC-VC-PAB-DM1 is part of an antibody-coupled reactive molecule with anticancer activity. -
BA2705 Azido-PEG4-Val-Cit-PAB-MMAESummary: Azido-PEG4-Val-Cit-PAB-MMAE is part of an antibody coupled active molecule (drug-linkerconjugateforADC). -
BA2706 MC-Val-Cit-PAB-clindamycinSummary: MC-Val-Cit-PAB-clindamycin is part of an antibody-coupled active molecule. -
BA2707 MC-Gly-Gly-Phe-Gly-GABA-ExatecanSummary: MC-Gly-Gly-Phe-Gly-GABA-ExatecanADC is a drug-linker coupler containing 22 μM topoisomerase. -
BA2708 Cyclooctyne-O-amido-PEG4-VC-PAB-Gly-Gly-NH-O-CO-ExatecanSummary: Cyclooctyne-O-amido-PEG4-VC-PAB-Gly-Gly-NH-O-CO-Exatecan be used as a drug-linker coupler for ADC. -
BA2709 Amino-PEG4-GGFG-DxdSummary: Can be used for ADC synthesis. -
BA2710 MC-Val-Cit-PAB-IndibulinSummary: MC-Val-Cit-PAB-Indibulin is part of an antibody-coupled active molecule. -
BA2711 Val-Ala-PABC-ExatecanSummary: Val-Ala-PABC-Exatecan is a drug-linker coupling compound (Drug-LinkerConjugatesforADC) consisting of cleavable Tesirinelinker and Exatecan (inhibitor, HY-13631). -
BA2712 Mc-MMADSummary: Mc-MMAD consists of the highly potent microtubule inhibitor MMAD coupled to the protective group maleimidocaproyl.

